Demirhan, AbdullahTekelioğlu, U. YaşarAkkaya, AkcanDağıstan, ElifAyhan, S. SuziÖztürk, SerkanYıldız, İlyas2021-06-232021-06-2320121128-3602https://hdl.handle.net/20.500.12491/7108https://www.webofscience.com/wos/woscc/full-record/WOS:000311020700031Gadobutrol is a contrast agent often used during magnetic resonance imaging (MRI). The agent has several side effects, some of which can be serious. It has extremely rare life-threatening systemic complications, which can lead to bronchospasm, hypersensitivity reactions and cardiovascular arrest. However, there is no data available on the development of noncardiogenic pulmonary edema following use of gadobutrol. This paper examines the case of a 37-year-old male patient reported to have developed noncardiogenic pulmonary edema after intravenous injection of gadobutrol during MRI.eninfo:eu-repo/semantics/closedAccessContrast AgentsGadobutrolMagnetic Resonance ImagingNoncardiogenic Pulmonary EdemaCase Report1611011223090824WOS:000311020700031Q4